Skip to main content

Ultramini-ECIRS vs. RIRS for high-burden multiple renal stones: A propensity score-matched retrospective cohort study

In brief

Ultramini-ECIRS clears stones in one session in 82% vs 35% with RIRS

In a matched retrospective study of 98 adults with multiple large kidney stones, 81.6% treated with ultramini-ECIRS were stone-free at one month, compared with 34.7% after RIRS. Complication rates and other measured safety outcomes were similar, but the single-center, nonrandomized results need confirmation in prospective trials.

Journal
Therapeutic advances in urology (Q1)
Published
26 October 2026
Study design
Prospective / inception cohort
Evidence level
Level 2, Moderate (CEBM 2b)
Authors
Jia-Jyun Jhang, Jie-De Wu, Yu-De Wang, Chao-Hsiang Chang, Hsi-Chin Wu, Tzung-Rue Li, et al.
PMID
43048573
DOI
10.1177/17562872261481967

Why clinicians should know about it

  • Picked for Urology (paper of the day, 21 November 2026): Comparative effectiveness of endoscopic approaches for renal stones

Abstract

BACKGROUND: Managing high-burden multiple renal stones remains a significant challenge. While retrograde intrarenal surgery (RIRS) is common, it often requires multiple stages for large stone burdens. OBJECTIVES: To evaluate the comparative outcomes, specifically efficacy and safety, of Ultramini-endoscopic combined intrarenal surgery (ECIRS) using a 12 Fr percutaneous sheath versus RIRS for high-burden multiple renal stones. DESIGN: Single-center retrospective propensity score-matched (PSM) cohort study. METHODS: We reviewed adult patients with high-burden multiple renal stones (≥3 stones, largest stone length >10 mm) who underwent Ultramini-ECIRS or RIRS between January 2020 and November 2024. PSM yielded 49 patients per group, balanced for stone area, length, density, and the presence of lower calyx stones. The primary outcome was the one-month stone-free rate (SFR), defined as the absence of residual fragments >4 mm. Assessment was performed via computed tomography (CT) for radiolucent stones and plain radiography (KUB) or CT for radiopaque stones. RESULTS: Ultramini-ECIRS was associated with significantly higher primary SFR (81.6% vs. 34.7%; OR: 12.50; 95% CI: 2.96-52.77; p<0.001) and final SFR (85.7% vs. 51.0%; OR: 5.25; 95% CI: 1.80-15.29; p<0.001). The stone reduction rate was also higher in the Ultramini-ECIRS group (97.5% vs. 71.6%, p<0.001). Subgroup analysis of lower calyx stones demonstrated a consistent clearance advantage for the combined approach. No significant differences were observed in operative time, hospital stay, hemoglobin decrease, or renal function changes. The incidence of postoperative Clavien-Dindo grade II or higher complications was comparable between Ultramini-ECIRS and RIRS group (24.5% vs. 36.7%, p=0.188). CONCLUSION: In this propensity score-matched cohort, Ultramini-ECIRS was associated with higher single-session SFR compared to RIRS for selected high-burden multiple renal stones with a comparable safety profile. These results suggest a potential role for Ultramini-ECIRS in managing complex stone distributions, particularly those involving the lower calyx. Further prospective randomized trials are warranted to further validate these findings.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.